Prévisions du marché européen des technologies PCR jusqu’en 2030 – Analyse régionale – par technologie (PCR en temps réel, PCR conventionnelle, PCR à transcription inverse, PCR numérique, PCR RT multiplex, PCR à démarrage à chaud et autres), offres (réactifs et consommables, instruments et Logiciels et services), application (analyse de l\'expression génique, séquençage génétique, génotypage, synthèse d\'acide nucléique, validation standard, diagnostics au point d\'intervention, application environnementale et autres) et utilisateur final (hôpitaux et centres de diagnostic, universités et instituts de recherche, laboratoires pharmaceutiques). et sociétés de biotechnologie, et autres)
Adoption croissante des techniques de PCR dans les pays émergents stimule le marché européen des technologies PCR
Les tests au point d\'intervention (POC) présentent une opportunité significative pour le marché de la technologie PCR en élargissant sa portée et ses applications. La technologie PCR, connue pour sa précision et sa sensibilité, est de plus en plus adaptée aux tests au point de service en raison de sa capacité à fournir des résultats rapides et fiables au point de service ou à proximité. À mesure que les tests POC deviennent plus répandus dans les établissements de soins de santé tels que les cliniques, les services d’urgence et les établissements décentralisés, la demande de plateformes et de tests PCR adaptés aux applications POC devrait augmenter.
Les avantages de la PCR, notamment la capacité de détecter les maladies infectieuses avec une spécificité et une sensibilité élevées, la rendent bien adaptée aux tests POC, en particulier dans les situations nécessitant un diagnostic et des décisions de traitement rapides. De plus, la miniaturisation et l\'automatisation des systèmes PCR permettent leur intégration dans les environnements POC, facilitant ainsi les tests sur site et améliorant les résultats des soins aux patients. Alors que les prestataires de soins de santé reconnaissent de plus en plus la valeur des tests PCR sur le lieu de soins pour améliorer les capacités de diagnostic et la prise en charge des patients, le marché des technologies PCR sur le lieu de soins est prêt pour la croissance et l\'innovation.
Aperçu du marché européen des technologies PCR
Le marché européen des technologies PCR est segmenté en Allemagne, au Royaume-Uni, en France, en Italie, en Espagne et dans le reste de l\'Europe. Les fonds mis à disposition par des organisations gouvernementales et privées pour la recherche avancée, le lancement de technologies innovantes pour la synthèse artificielle de l\'ADN et l\'augmentation de diverses études de recherche pour de nouvelles applications basées sur la technologie stimulent la croissance du marché des technologies PCR en Europe. En outre, les efforts déployés par les gouvernements nationaux pour encourager l’innovation par le biais de dispositions incitatives et d’exonérations fiscales pour la R&D et les nouvelles start-ups biotechnologiques devraient favoriser la croissance du marché européen des technologies PCR au cours de la période de prévision. L\'Allemagne est l\'un des plus grands pôles de biotechnologie en Europe et dans le monde en raison de la présence d\'acteurs biotechnologiques de premier plan, de laboratoires de recherche de haute technologie et d\'un financement massif pour mener des activités de recherche et de développement dans les nouveaux domaines scientifiques et technologiques. Le pays compte plus d’entreprises de biotechnologie que tout autre pays européen. La recherche de pointe et de haute qualité en cours en Allemagne crée des opportunités lucratives pour le marché déjà établi des technologies PCR. Des chercheurs individuels et des universités universitaires du pays collaborent avec des laboratoires et des institutions internationales pour créer des innovations révolutionnaires. L’augmentation des fonds et des subventions ainsi que l’utilisation croissante de la biologie synthétique dans divers domaines d’application sont les principaux facteurs favorisant la croissance du marché allemand des technologies PCR. Le gouvernement allemand considère la création de startups comme un élément essentiel du développement de l’industrie biotechnologique dans le pays. Par exemple, BIO Deutschland est une association sectorielle de l\'industrie biotechnologique allemande basée à Berlin, avec plus de 330 membres qui promeuvent et soutiennent le développement de l\'industrie pour l\'aider à s\'épanouir en tant qu\'entité économique robuste. De même, Euronext est une autre organisation qui reconnaît et exploite la dynamique actuelle de l’industrie biotechnologique. Il accompagne ainsi les startups en créant des emplois, en levant des fonds et des investissements, et en soutenant les entreprises de diverses autres manières.
Revenus et prévisions du marché européen des technologies PCR jusqu\'en 2030 (millions de dollars américains)
Segmentation du marché européen des technologies PCR
Le marché européen des technologies PCR est segmenté en technologie, offres et applications. , l\'utilisateur final et le pays.
Basé sur la technologie, le marché européen des technologies PCR est classé en PCR en temps réel, PCR conventionnelle, transcription inverse, PCR numérique, RTPCR multiplex, PCR à démarrage à chaud et autres. Le segment PCR en temps réel détenait la plus grande part du marché européen des technologies PCR en 2022.
En termes d\'offres, le marché européen des technologies PCR est segmenté en réactifs et consommables, instruments, logiciels et services. Le segment des réactifs et consommables détenait la plus grande part du marché européen des technologies PCR en 2022. En outre, le segment des réactifs et consommables est classé en réactifs, taille de flacons et autres consommables. De plus, la taille des flacons est segmentée en 0,2 ml à 2 ml, 0,1 ml à 0,3 ml, 2 ml à 5 ml et autres flacons. De plus, le segment des instruments est divisé en PCR de paillasse et thermocycleurs/PCR portables.
Par application, le marché européen des technologies PCR est segmenté en analyse de l\'expression génique, séquençage génétique, génotypage, synthèse d\'acide nucléique, validation standard, application de diagnostic sur le lieu de soins, application environnementale et autres. Le segment de l\'analyse de l\'expression génique détenait la plus grande part du marché européen des technologies PCR en 2022.
En fonction de l\'utilisateur final, le marché européen des technologies PCR est segmenté en hôpitaux et centres de diagnostic, sociétés pharmaceutiques et biotechnologiques, instituts universitaires et recherche. laboratoires et autres. Le segment des hôpitaux et des centres de diagnostic détenait la plus grande part du marché européen des technologies PCR en 2022.
Par pays, le marché européen des technologies PCR a été classé en Allemagne, au Royaume-Uni, en France, en Italie, en Espagne et dans le reste. de l\'Europe. L\'Allemagne a dominé le marché européen des technologies PCR en 2022.
Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Takara Bio Inc. , Standard Bio Tools Inc, Agilent Technologies Inc et Ellume Ltd font partie des principales sociétés opérant sur le marché européen des technologies PCR.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe PCR Technologies Market - Key Industry Dynamics
4.1 PCR Technologies Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Rising Prevalence of Genetic and Infectious Diseases
4.2.2 Surging Investments and Funds Availability for PCR Technologies
4.3 Market Restraints
4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
4.4 Market Opportunities
4.4.1 Increasing Demand for POC Testing
4.5 Future Trends
4.5.1 Advancements in PCR Technologies
4.6 Impact of Drivers and Restraints:
5. PCR Technologies Market - Europe Market Analysis
5.1 PCR Technologies Market Revenue (US$ Million), 2020 - 2030
6. Europe PCR Technologies Market Analysis - By Technology
6.1 Overview
6.2 Real Time PCR
6.2.1 Overview
6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Conventional PCR
6.3.1 Overview
6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Reverse Transcription PCR
6.4.1 Overview
6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.5 Digital PCR
6.5.1 Overview
6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.6 Multiplex RT PCR
6.6.1 Overview
6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.7 Hot Start PCR
6.7.1 Overview
6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.8 Others
6.8.1 Overview
6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
7. Europe PCR Technologies Market Analysis - By Offerings
7.1 Overview
7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
7.3 Reagents and Consumables
7.3.1 Overview
7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
7.3.2.1.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
7.5 Software and Services
7.5.1 Overview
7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)
8. Europe PCR Technologies Market Analysis - By Application
8.1 Overview
8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Gene Expression Analysis
8.3.1 Overview
8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Genetic Sequencing
8.4.1 Overview
8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
8.5 Genotyping
8.5.1 Overview
8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
8.6 Nucleic Acid Synthesis
8.6.1 Overview
8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
8.7 Standard Validation
8.7.1 Overview
8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
8.8 Point of Care Diagnostics
8.8.1 Overview
8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
8.9 Environmental Application
8.9.1 Overview
8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
8.10 Others
8.10.1 Overview
8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
9. Europe PCR Technologies Market Analysis - By End User
9.1 Overview
9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals and Diagnostic Centers
9.3.1 Overview
9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Academia and Research Institutes
9.4.1 Overview
9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
9.5 Pharmaceutical and Biotechnology Companies
9.5.1 Overview
9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
10. Europe PCR Technologies Market -Country Analysis
10.1 Europe: PCR Technologies Market
10.1.1 Overview
10.1.2 Europe PCR Technologies Market Revenue and Forecast and Analysis - By Country
10.1.2.1 Germany
10.1.2.1.1 Overview
10.1.2.2 Germany PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.2.1 Germany PCR Technologies Market Breakdown by Technology
10.1.2.2.2 Germany PCR Technologies Market Breakdown by Offerings
10.1.2.2.2.1 Germany PCR Technologies Market Breakdown by Instruments
10.1.2.2.2.2 Germany PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.2.2.2.1 Germany PCR Technologies Market Breakdown by Vial Size
10.1.2.2.3 Germany PCR Technologies Market Breakdown by Application
10.1.2.2.4 Germany PCR Technologies Market Breakdown by End User
10.1.2.3 United Kingdom
10.1.2.3.1 Overview
10.1.2.4 United Kingdom PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.4.1 United Kingdom PCR Technologies Market Breakdown by Technology
10.1.2.4.2 United Kingdom PCR Technologies Market Breakdown by Offerings
10.1.2.4.2.1 United Kingdom PCR Technologies Market Breakdown by Instruments
10.1.2.4.2.2 United Kingdom PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.4.2.2.1 United Kingdom PCR Technologies Market Breakdown by Vial Size
10.1.2.4.3 United Kingdom PCR Technologies Market Breakdown by Application
10.1.2.4.4 United Kingdom PCR Technologies Market Breakdown by End User
10.1.2.5 France
10.1.2.5.1 Overview
10.1.2.6 France PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.6.1 France PCR Technologies Market Breakdown by Offerings
10.1.2.6.1.1 France PCR Technologies Market Breakdown by Instruments
10.1.2.6.1.2 France PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.6.1.2.1 France PCR Technologies Market Breakdown by Vial Size
10.1.2.6.2 France PCR Technologies Market Breakdown by Application
10.1.2.6.3 France PCR Technologies Market Breakdown by End User
10.1.2.7 Italy
10.1.2.7.1 Overview
10.1.2.8 Italy PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.8.1 Italy PCR Technologies Market Breakdown by Technology
10.1.2.8.2 Italy PCR Technologies Market Breakdown by Offerings
10.1.2.8.2.1 Italy PCR Technologies Market Breakdown by Instruments
10.1.2.8.2.2 Italy PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.8.2.2.1 Italy PCR Technologies Market Breakdown by Vial Size
10.1.2.8.3 Italy PCR Technologies Market Breakdown by Application
10.1.2.8.4 Italy PCR Technologies Market Breakdown by End User
10.1.2.9 Spain
10.1.2.9.1 Overview
10.1.2.10 Spain PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.10.1 Spain PCR Technologies Market Breakdown by Technology
10.1.2.10.2 Spain PCR Technologies Market Breakdown by Offerings
10.1.2.10.2.1 Spain PCR Technologies Market Breakdown by Instruments
10.1.2.10.2.2 Spain PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.10.2.2.1 Spain PCR Technologies Market Breakdown by Vial Size
10.1.2.10.3 Spain PCR Technologies Market Breakdown by Application
10.1.2.10.4 Spain PCR Technologies Market Breakdown by End User
10.1.2.11 Rest of Europe
10.1.2.11.1 Overview
10.1.2.12 Rest of Europe PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.12.1 Rest of Europe PCR Technologies Market Breakdown by Technology
10.1.2.12.2 Rest of Europe PCR Technologies Market Breakdown by Offerings
10.1.2.12.2.1 Rest of Europe PCR Technologies Market Breakdown by Instruments
10.1.2.12.2.2 Rest of Europe PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.12.2.2.1 Rest of Europe PCR Technologies Market Breakdown by Vial Size
10.1.2.12.3 Rest of Europe PCR Technologies Market Breakdown by Application
10.1.2.12.4 Rest of Europe PCR Technologies Market Breakdown by End User
11. PCR Technologies Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the PCR Technologies Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Promega Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN NV
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 bioMerieux SA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Hoffmann-La Roche Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bio-Rad Laboratories Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Becton Dickinson and Co
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Takara Bio Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Standard Biotools Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Agilent Technologies Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Ellume Ltd
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. PCR Technologies Market Segmentation
Table 2. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Technology
Table 3. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Offerings
Table 4. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
Table 5. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
Table 6. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
Table 7. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Application
Table 8. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By End User
Table 9. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 10. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 11. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 12. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 13. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 14. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 15. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 16. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 17. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 18. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 19. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 20. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 21. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 22. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 23. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 24. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 25. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 26. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 27. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 28. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 29. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 30. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 31. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 32. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 33. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 34. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 35. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 36. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 37. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 38. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 39. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 40. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 41. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 42. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 43. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 44. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 45. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 46. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 47. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 48. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 49. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 50. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 51. Recent Inorganic Growth Strategies in the PCR Technologies Market
Table 52. Recent Organic Growth Strategies in the PCR Technologies Market
Table 53. Glossary of Terms, PCR Technologies Market
List of Figures
Figure 1. PCR Technologies Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. PCR Technologies Market Revenue (US$ Million), 2020 - 2030
Figure 4. PCR Technologies Market Share (%) - By Technology, 2022 and 2030
Figure 5. Real Time PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Conventional PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Reverse Transcription PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Digital PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. Multiplex RT PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 10. Hot Start PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. PCR Technologies Market Share (%) - By Offerings, 2022 and 2030
Figure 13. Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Instruments Market Revenue and Forecasts to 2030 (US$ Million)
Figure 15. Software and Services Market Revenue and Forecasts to 2030 (US$ Million)
Figure 16. PCR Technologies Market Share (%) - By Application, 2022 and 2030
Figure 17. Gene Expression Analysis Market Revenue and Forecasts to 2030 (US$ Million)
Figure 18. Genetic Sequencing Market Revenue and Forecasts to 2030 (US$ Million)
Figure 19. Genotyping Market Revenue and Forecasts to 2030 (US$ Million)
Figure 20. Nucleic Acid Synthesis Market Revenue and Forecasts to 2030 (US$ Million)
Figure 21. Standard Validation Market Revenue and Forecasts to 2030 (US$ Million)
Figure 22. Point of Care Diagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 23. Environmental Application Market Revenue and Forecasts to 2030 (US$ Million)
Figure 24. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 25. PCR Technologies Market Share (%) - By End User, 2022 and 2030
Figure 26. Hospitals and Diagnostic Centers Market Revenue and Forecasts to 2030 (US$ Million)
Figure 27. Academia and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
Figure 28. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
Figure 29. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 30. Europe: PCR Technologies Market, by Key Country - Revenue (2022) (US$ Million)
Figure 31. Europe PCR Technologies Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 32. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 33. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 34. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 35. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 36. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 37. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 38. Growth Strategies in the PCR Technologies Market
1. Thermo Fisher Scientific Inc
2. Promega Corp
3. QIAGEN NV
4. bioMerieux SA
5. Hoffmann-La Roche Ltd
6. Bio-Rad Laboratories Inc
7. Becton Dickinson and Co
8. Takara Bio Inc
9. Standard BioTools Inc
10. Agilent Technologies Inc
11. Ellume Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe PCR technologies market.
- Highlights key business priorities to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Europe PCR technologies market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.